0001144204-18-042956.txt : 20180808 0001144204-18-042956.hdr.sgml : 20180808 20180808214349 ACCESSION NUMBER: 0001144204-18-042956 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180807 FILED AS OF DATE: 20180808 DATE AS OF CHANGE: 20180808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRANZLER JAY D CENTRAL INDEX KEY: 0001055666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38114 FILM NUMBER: 181002982 MAIL ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE STREET 2: SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001644963 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474113275 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 tv500467_form4.xml FORM 4 X0306 4 2018-08-07 0 0001644963 AVENUE THERAPEUTICS, INC. ATXI 0001055666 KRANZLER JAY D C/O AVENUE THERAPEUTICS, INC. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 0 0 0 Common Stock 2018-08-07 4 G 0 14663 0 A 64663 D The 14,663 shares of restricted common stock will vest on August 7, 2021. Includes 64,663 shares of restricted stock. /s/ Lucy Lu, M.D., Attorney-in-Fact 2018-08-08